secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2026-04-13T23:59:59+00:00
Accession:  0001104659-26-042362
Event type: leadership
Sentiment:  positive
Materiality: 0.45
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth appoints veteran healthcare exec John R. Palumbo to board to support commercial scaling
--------------------------------------------------------------------------------

- John R. Palumbo, age 75, appointed to DarioHealth board effective April 10, 2026.
- Brings over 40 years healthcare experience incl. senior roles at AmerisourceBergen and Allscripts.
- Appointment aims to accelerate commercial scaling and channel partnerships per CEO Erez Raphael.
- Also serves on boards of Lucid Diagnostics (LUCD), PM Pediatrics, ivWatch, and QLess.
- Will receive standard non-executive director fees; no material transactions to disclose.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465926042362/0001104659-26-042362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465926042362/tm2611605d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-042362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer